期刊文献+

DKK1基因沉默的人多发性骨髓瘤细胞培养上清对小鼠前成骨细胞成骨分化的影响 被引量:2

Effect of culture supernatant of human multiple myeloma cells with DKK1 gene silencing on osteogenic differentiation of mouse preosteoblasts
下载PDF
导出
摘要 目的:初步探讨一种与胚胎发生及肿瘤发展密切相关的糖蛋白Dickkopf-1(DKK1)在骨髓瘤骨病(myeloma bone disease,MBD)发病中的作用。方法:前期实验构建的质粒pLenti6/V5-GW/DKK-1-miR,与慢病毒包装质粒一起包装成慢病毒,感染人骨髓瘤U266细胞,建立DKK1沉默的U266细胞。小鼠前成骨细胞MC3T3-E1体外成骨诱导实验分组:空白对照组、诱导分化组、30%U266上清干预组、30%DKK1 RNAi U266上清干预组和30%无关序列RNAi U266上清干预组;诱导培养12 d后,通过茜素红染色检测钙结节数目;real-time PCR检测骨钙素(osteocalcin,OC)mRNA的表达变化。结果:成骨诱导体系中,与空白组比较,诱导组OC mRNA有明显升高,差异有统计学意义(P<0.01)。与诱导组比较,30%U266上清干预组OC mRNA表达明显减少(P<0.01)。与30%U266上清干预组比较,30%DKK1 RNAi U266上清干预组OC mRNA表达明显增多(P<0.05),30%无关序列RNAi U266上清干预组OC mRNA差异无统计学意义。与诱导组比较,30%U266上清干预组钙结节计数明显减少(P<0.01)。与30%U266上清干预组比较,30%DKK1 RNAi U266上清干预组钙结节计数明显增多(P<0.05),30%无关序列RNAi U266上清干预组钙结节计数差异无统计学意义(P>0.05)。结论:U266细胞中DKK1基因沉默后,其培养上清抑制小鼠前成骨细胞MC3T3-E1成骨分化的能力减弱。 AIM: To investigate the effect of Dickkopt-1 (DKK/) gene on myeloma bone disease. METH- ODS: Lentivirus was packed with pLenti6/VS-GW/DKK-I-miR plasmids and lentivirus packaging plasmids, and then transfected into human multiple myeloma cell line U266. An in vitro osteogenic experiment was performed and the mouse MC3T3-E1 preosteoblasts were divided into blank control group, bone morphogenetic protein 2 (BMP-2) induction group, U266 supernatant group, DKK/ RNAi U266 supernatant group and negative RNAi U266 supernatant group. All superna- tants added to the cells were at the concentration of 30%. After culture for 12 d, the effects of different U266 cell superna- tants on osteogenic differentiation of MC3T3-E1 ceils were investigated by alizarin red staining. The mRNA expression of osteocalcin (OC) was detected by real-time PCR. RESULTS: Compared with blank control group, the mRNA expression of OC in BMP-2 induction group increased significantly. Compared with BMP-2 induction group, the mRNA expression of OC and the number of calcium nodule in U266 supernatant group were decreased. Compared with U266 supernatant group, the mRNA expression of OC and the number of calcium nodule in DKK/ RNAi supernatant group were significantly eleva- ted. In negative RNAi U266 supernatant group, OC mRNA and the calcium nodule did not change significantly. CON- CLUSION: After DKK/ gene silencing in U266 cells by RNAi, the inhibition of osteogenic differentiation of mouse preos- teoblasts significantly decreases.
作者 章瑜 俞康
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2013年第6期1129-1132,共4页 Chinese Journal of Pathophysiology
基金 温州医学院5010重大项目子课题(No.XNK05005)
关键词 Dickkopf-1蛋白 骨髓瘤骨病 骨钙素 Dickkopf-1 protein Myeloma bone disease Osteocalcin
  • 相关文献

参考文献13

  • 1Roodman GD. New potential targets for treating myeloma bone disease[J]. Clin Cancer Res, 2006, 12(20 Pt2): 6270s-6273s.
  • 2Sezer O. Myeloma bone disease: recent advances in biology, diagnosis, and treatment [J]. Oncologist, 2009, 14 (3) :276-283.
  • 3Saad F, Lipton A, Cook R, et al. Pathologic fractures correlate with reduced survival in patients with malignant bone disease[J]. Cancer, 2007,110(8) :1860-1867.
  • 4Sonmez M, Akagun T, Topbas M, et al. Effect of pathologic fractures on survival in multiple myeloma patients: a case control study[J]. J Exp Clin Cancer Res, 2008,27: 11.
  • 5Pearse RN, Sordillo EM, Yaccoby S, et al. Multiple myeloma disrupts the TRANCE/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression [J]. Proc Natl Acad Sci USA, 2001,98(20):11581- 11586.
  • 6汤丽苑,徐钰,陈瑾,刘新华,俞康.人多发性骨髓瘤RPMI 8226细胞条件培养液诱导破骨前体细胞的分化成熟[J].中国病理生理杂志,2012,28(4):649-654. 被引量:4
  • 7Berenson JR. Zoledronic acid in cancer patients with bone metastases: results of Phase I and II trials[J]. Semin Oncol, 2001, 28(2 Suppl 6) :25-34.
  • 8Pinzone 11 , Hall BM, Thudi NK, et al. The role of Dickkopf-1 in bone development, homeostasis, and disease [J]. Blood, 2009,113 (3) :517-525.
  • 9Gunn WG, Conley A, Deininger L, et al. A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6, a potential role in the development of lytic bone disease and tumor progression in multiple myeloma [J]. Stem Cells, 2006,24 ( 4 ) : 986-991.
  • 10Fulciniti M, Tassone P, Hideshima T, et al. Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myelomaj L]. Blood, 2009,114(2) :371-379.

二级参考文献17

  • 1Roodman GD.New potential targets for treating myeloma bone disease[J].Clin Cancer Res,2006,15(20):6270-6273.
  • 2E.Voskaridou,D.Christoulas,C.Xirakia,et al.Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis.Reduction post-zoledronic acid administration.Haematologica,2009,94(5):725-728.
  • 3Sastry L,Johnson T,Hobson MJ,et al.Titering Lentiviral vectors:comparison of DNA,RNA and marker expression methods[J].Gene Ther,2002,9(17):1155-1162.
  • 4Pearse RN,Sordillo EM,Yaccoby S,et al.Multiple myeloma disrupts the TRANCE/osteopr-otegerin cytokine axis to trigger bone destruction and promote tumor progression[J].Proc Natl Acad Sci USA,2001,98(20):11581-11586.
  • 5Berenson JR.Zoledronic acid in cancer patients with bone metastases:results of Phase I and II trials[J].Semin Oncol,2001,28(2):25-34.
  • 6Tian,B.S,Fenghuang Zhan,Ph.D,et al.The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma[J] The New England Journal of Medicine,2003,349(26):2483-2494.
  • 7Haaber J,Abildgaard N,Knudsen LM,et al.Myeloma cell expression of 10 candidate genes for osteolytic bone disease.Only overexpression of DKK1 correlates with clinical bone involvement at diagnosis[J].Br J Haematol,2008,140(1):25-35.
  • 8Cockrell AS,KafriGene T.delivery by lentivirus vectors[J].Mol Biotechnol,2007,36(3):184-204.
  • 9Boyce BF,Xing L.Functions of RANKL/RANK/OPG inbone modeling and remodeling[J].Arch Biochem Bio-phys,2008,473(2):139-146.
  • 10Roodman GD.Pathogenesis of myeloma bone disease[J].Leukemia,2009,23(3):435-441.

共引文献4

同被引文献16

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部